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ABSTRACT
Background and Objectives: Although there have been so many reports of catheter ablation of atrial fibrillation (AF) with 
magnetic navigation system (MNS), it is not necessarily obvious that MNS is more effective than conventional ablation. We 
performed AF ablation with MNS and compared the clinical outcomes and radiofrequency ablation parameters with those of 
conventional ablation. Subjects and Methods: One hundred eleven consecutive patients (conventional group, n=70 vs. MNS 
group, n=41) undergoing catheter ablation of AF were enrolled. We compared and analyzed the procedural parameters, name-
ly fluoroscopic time, procedural time, acute procedural success and 3 months success rate of both groups. Results: The MNS 
group was associated with slightly larger left atrial size (43.7±6.3 mm vs. 41.2±6.3 mm, p=0.04), significantly longer total proce-
dure time (352±50 minutes vs. 283±75 minutes, p<0.0001), and shorter total fluoroscopic time (99±28 minutes vs. 238±45 
minutes, p<0.0001) than the conventional group. The MNS and conventional group did not differ with respect to acute pro-
cedural success, AF recurrence, atrial flutter/atrial tachycardia recurrence, or total arrhythmia recurrence. While no compli-
cations were observed in the MNS group, eight cases of significant pericardial effusion occurred in the conventional group. 
Conclusion: The MNS system seems to be effective and safe in the catheter ablation of AF, particularly in the population of 
patients with persistent AF and slightly dilated left atria. (Korean Circ J 2011;41:248-252)
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Introduction
 Remote catheter manipulation is a major technological ad-
vancement for ablation procedure. Since its first published re-
port in humans in 2002,
1) its efficacy in the treatment of var-
ious arrhythmias has been demonstrated.
2-4) It may also re-
duce radiation exposure and physical stress to the operator 
and could thus theoretically enhance the safety and efficacy 
of the procedure due to the unrestricted and more precise ca-
theter movement.
6)
Although previous studies have shown remote magnetic 
navigation to be feasible for atrial fibrillation (AF), the bene-
fits of this navigation modality relative to conventional man-
ual technique remain unclear.
5)
The aim of this study is to compare overall fluoroscopy time 
and procedural duration of the magnetic navigation system 
(MNS) with conventional ablation and to report our initial 
short term clinical outcomes of magnetic ablation in AF. 
Subjects and Methods 
Patient population
One hundred eleven consecutive patients (mean age: 56± 
11 years, M : F=84 : 27) undergoing AF ablation were enrolled Min Seok Choi, et al.   249
in this study. All patients were drug refractory symptomatic 
AF patients. Patients with contraindications for the use of 
MNS were excluded. 
 
Electrophysiological study 
After informed consent was obtained, the patients were stu-
died in the fasting state and all antiarrhythmic drugs were ceas-
ed at least five half-lives prior to procedure. Continuous seda-
tion and analgesia was achieved by intravenous bolus admi-
nistration of midazolam (2.5-5 mg) and administration of 
fentanyl (30-50 mg). One multipolar (5 Fr) and two decapo-
lar (6 Fr) catheters were introduced via the right internal 
jugular vein and the left femoral vein, respectively. The cath-
eters were positioned in the right atrium, coronary sinus, his 
bundle and right ventricle for the diagnostic electrophysio-
logic study. Double trans-septal puncture was performed us-
ing the Brokenbrough needle and two sheaths (SL1, Saint-Jude 
Medical, Minnetonka, MN, USA and Multipurpose, Biosense 
Webster, Diamond Bar, CA, USA) were used for left atrium 
access. A circular Lasso catheter (30 mm to 45 mm or variable 
sized, Biosense Webster, Diamond Bar, CA, USA) was posi-
tioned at each pulmonary antrum and used to assess electrical 
conductivity. To reduce radiation exposure, we set fluoroscopy 
at 6 nGy/p with a pulse rate of 10/sec.
Magnetic navigation system 
The MNS (Niobe, Stereotaxis, St-Louis, MO, USA) consists 
of two permanent magnets, each weighing 1.8 tons, position-
ed at either side of the fluoroscopy table (Axiom Artis, Si-
mens, Germany) to create a magnetic field vector (0.1 T) ap-
proximately 15 cm inside the chest of the patient, that can be 
manipulated remotely. 
The soft magnetic catheters are equipped with three mag-
nets near its distal tips which align to the orientation of the 
magnetic field. All magnetic field vectors can be stored and 
reapplied in order to facilitate accurate navigation. A compu-
ter-controlled catheter advancement system is used to allow 
remote advancement and retraction of the catheter. The Navi-
gant II workstation, when used in conjunction with the Car-
diodrive unit, allows the operator to control the catheter’s po-
sition with 1 mm step and at 1° angle precision. 
The MNS was used with the CARTO mapping system to 
produce 3-D anatomical maps which were then integrated 
with 3D CT images using CARTO-Merge. The system is con-
trolled remotely by mouse and joystick from a radiation-sh-
ielded control room. 
Catheter ablation
Left atrial access was achieved by the trans-septal approach. 
The irrigated magnetic mapping and ablation catheter (3.5 
mm Navistar thermocool RMT, Biosense-webster, Diamond 
Bar, CA, USA) was introduced manually into the left atrium, 
and radiofrequency catheter ablation was performed in a tem-
perature controlled mode (maximum temperature 39°C, ma-
ximum duration 120 seconds, maximum 40 W). 
Conventional ablation was accomplished by standard tech-
nique using 4 mm ablation and mapping catheter (3.5 mm 
Navistar thermocool, Biosense-webster, Diamond Bar, CA, 
USA) in a temperature controlled mode (maximum tempera-
ture 39°C, maximum duration 120 seconds, maximum 35 W). 
For paroxysmal AF interventions, electrical isolation was 
achieved by antral ablation with carina, roof and posterior 
lines. Posterior line was defined as linear line connecting pos-
terior lower portion of both antral lines. For persistent AF in-
terventions, the operator produced an anterior ablation line 
which connected roof line and anterior mitral annulus th-
rough the medial side of the left atrial appendage. Electrical 
block was confirmed by measuring electrical potentials at 
the left atrial appendage, using the Lasso catheter. 
We defined complete antral isolation as a lack of PV poten-
tial recorded by a small Lasso placed in the ipsilateral upper 
and lower PVs, after same side antral ablation. Acute success 
was defined as non-inducibility of AF, atrial flutter, or tachycar-
dia during rapid atrial pacing between 250 ms and 200 ms, 
with less than 5 μgm/min of isoproterenol. Total procedure 
time is defined from arrival of patient to electrophysiology 
room to sheath out time. Total arrhythmia recurrence is de-
fined as the sum of AF and atrial flutter/atrial tachycardia re-
currence. 
Immediately following ablation, the operator checked, with 
echocardiography, for evidence of pericardial effusion. Signifi-
cant pericardial effusion was defined as more than 5 mm of 
newly developed effusion with a 6-10 mmHg drop in systolic 
blood pressure.
Follow up of patients
During the three months following the initial ablation pro-
cedure, all patients underwent monthly follow-up with EKG 
and ambulatory electrocardiogram monitoring as needed. 
All patients were instructed to report symptomatic palpitations 
during this period. Mid-term success was defined as a lack of 
electrocardiographically evident atrial tachycardia or AF.
Statistical analysis
The Statistical Package for the Social Sciences (SPSS) for Win-
dows, version 15.0 (Chicago, IL, USA) was used for all analy-
sis. Continuous variables are presented as mean values±st-
andard deviation and were compared using unpaired Stu-
dent’s t-tests. A p of less than 0.05 was considered statistically 
significant. 
Results
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mographics, procedural characteristics and clinical outcomes 
are presented in Table 1. 
These groups did not differ significantly with respect to age, 
sex, body mass index (BMI), or underlying disease (including 
hypertension, diabetes, and coronary artery disease) (Table 1). 
Left atrial diameter was observed to be mildly enlarged and 
ejection fraction (EF) was normal.
Total procedure time was significantly longer (352±50 
minutes vs. 283±75 minutes, p<0.0001) and total fluorosco-
py time was significantly shorter (99±28 minutes vs. 238±45 
minutes, p<0.0001) in the MNS group compared to the con-
ventional group. Although not statistically significant, acute 
procedural success rate was lower in the MNS group than in 
the manual group (85% vs. 90%, p=0.08). 
In the conventional group, eight cases of cardiac tamponade 
occurred, five of which required pericardiocentesis. One pa-
tient in the conventional group suffered a transient ischemic 
attack (TIA). No cardiac tamponade, stroke, or TIA occurr-
ed in the MNS group (Table 2).
The two groups did not differ in terms of AF, atrial flutter/at-
rial tachycardia, or total arrhythmia recurrence rates at 3 mon-
th follow-up (Table 2).
This total population was divided into paroxysmal (n=67) 
and persistent (n=44) AF subgroups.
Paroxysmal atrial fibrillation
A total of 67 patients with paroxysmal AF underwent ca-
theter ablation with conventional (n=43) and MNS (n=24) na-
vigation. These groups did not differ significantly with respect 
to age, sex, BMI, or underlying disease (including hyperten-
sion, diabetes, and coronary artery disease) (Table 3). Left at-
rial diameter was not statistically different and EF was normal. 
Total procedure time was significantly longer (321±52 mi-
nutes vs. 273±74 minutes, p=0.03) and total fluoroscopy time 
was significantly shorter (105±28 minutes vs. 234±53 min-
utes, p<0.0001) in the MNS group compared to the conven-
tional group. Although not statistically significant, acute pro-
cedural success rate was lower in the MNS group than in the ma-
nual group (79% vs. 90%, p=0.19). 
In the conventional group, five cases of significant pericar-
dial effusion occurred, three of which required pericardiocen-
tesis. One patient in the conventional group suffered a TIA. 
No cardiac tamponade, stroke, or TIA occurred in the MNS 
group (Table 4). The two groups did not differ in terms of AF, 
Table 1. Baseline patient characteristics
Conventional (n=70) MNS (n=41) p
Age (years) 055±11  057±11  0.55 
Male, n (%) 54 (77)  31 (75)  0.97
BMI (kg/cm
2) 25.0±3.7  25.0±5.5  0.49 
LAD (mm) 41.2±6.3  43.7±6.3  0.04 
EF (%) 60.3±6.6  59.9±6.6  0.99 
HTN (%) 30 (42)  15 (36)  0.78 
DM (%) 09 (13) 06 (14)  0.70
CAD (%) 07 (10) 4 (9)  0.99
MNS: magnetic navigation system, BMI: body mass index, LAD: left  
atrial diameter, HTN: hypertension, CAD: coronary artery disease







Total procedure time (minute) 283±75  352±50 <0.0001
Total fluoroscopic time (minute) 238±45 099±28 <0.0001
Acute procedural success, n (%) 63 (90)  34 (85)  0.28 
Significant PE, n (%) 08 (11)  0 (0)  NA
Stroke/TIA, n (%) 1 (1)  0 (0)   NA 
Total arrhythmia recurrence, n (%) 12 (17)  07 (17)  0.99 
AF recurrence, n (%) 5 (7)  04 (10)  0.79
AFL/AT recurrence, n (%) 07 (10)  3 (7)  0.64
MNS: magnetic navigation system, PE: pericardial effusion, AF: atri-
al fibrillation, AFL: atrial flutter, AT: atrial tachycardia, NA: not 
applicable
Table 3. Baseline patient characteristics in paroxysmal atrial fibril-
lation
Conventional (n=43) MNS (n=24) p
Age (years) 054±12  056±12  0.52 
Male, n (%) 32 (74)  19 (79)  0.67
BMI (kg/cm
2) 25.0±2.3  26.0±4.4  0.49 
LAD (mm) 40.2±6.2  41.4±6.9  0.59 
EF (%) 61.0±5.5  61.3±4.9  0.99 
HTN (%) 13 (30)  10 (41)  0.35 
DM (%) 07 (16)  03 (12)  0.68
CAD (%) 06 (13)  2 (8)  0.50
MNS: magnetic navigation system, BMI: body mass index, LAD: left 
atrial diameter, HTN: hypertension, CAD: coronary artery disease
Table 4. Procedure parameters and acute/midterm procedural suc-






Total procedure time (minute) 273±74  321±52  0.03
Total fluoroscopic time (minute) 234±53 105±28 <0.0001
Acute procedural success, n (%) 39 (90)  19 (79)  0.19 
Significant PE, n (%) 05 (12)  0 (0)  NA
Stroke/TIA, n (%)  1 (1)  0 (0)   NA 
Total arrhythmia recurrence  
  rate, n (%)
05 (11)  03 (13)  0.93 
AF recurrence, n (%) 2 (4)  1 (4)  0.94
AFL/AT recurrence, n (%) 3 (6)  2 (8)  0.84
MNS: magnetic navigation system, PE: pericardial effusion, AF: atri-
al fibrillation, AFL: atrial flutter, AT: atrial tachycardia, NA: not ap-
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atrial flutter/atrial tachycardia, or total arrhythmia recurr-
ence rates at 3 month follow-up (Table 4). 
Persistent atrial fibrillation
A total of 44 patients with persistent AF underwent catheter 
ablation with either conventional (n=27) or magnetic (n=17) 
navigation. These groups did not differ significantly with re-
spect to age, sex, BMI, or underlying disease (including hyper-
tension, diabetes, and coronary artery disease) (Table 5). Left 
atrial diameter was observed to be mildly enlarged and EF 
was normal. 
Total procedure time was significantly longer (358±54 mi-
nutes vs. 294±77 minutes, p=0.01) and total fluoroscopy time 
was significantly shorter (98±46 minutes vs. 234±75 minutes, 
p<0.0001) in the MNS group compared to the conventional 
group. The MNS group did not differ significantly from the 
conventional group with respect acute success rate (88% vs. 
88%, p=0.92).
In the conventional group, four cases of significant pericar-
dial effusion occurred, two of which required pericardiocen-
tesis. No cardiac tamponade, stroke, or TIA occurred in the 
MNS group (Table 2). The two groups did not differ in terms 
of AF, atrial flutter/atrial tachycardia, or total arrhythmia re-
currence rates at the 3 month follow-up (Table 6). 
Discussion
Our initial experience with the MNS demonstrates that the 
system is effective for ablation of both paroxysmal and per-
sistent AF, with outcomes comparable to what is observed 
with manual technique. The results support the safety of the 
MNS, which was not found to be associated with any compli-
cations or incidents of significant pericardial effusion.
Acute procedural success rates were similar in both groups 
and were consistent with previously published data. AF ablation 
is a complex and operator dependent procedure. Although 
Papone et al. reported that MNS-guided AF ablation was sim-
ple and did not require a long learning curve. We found that 
MNS procedures were significantly longer for patients with 
both paroxysmal and persistent AF.
6) Our results, however, 
support the observation of Di Biase et al.
7) in that fluoroscopy 
times are reduced with use of MNS. Frequent dislodgment of 
the Lasso catheter may account for our longer fluoroscopy 
times.
Di Biase et al.
7) reported low rates of acute success for MNS-
guided AF ablation and attribute these results to the unavail-
ability of irrigated tip catheters. As expected, the present study 
demonstrates a remarkable improvement in procedural suc-
cess compared to previously reported data as a result of the 
incorporation of irrigated tip magnetic catheters following 
their commercial release. Despite the stability of magnetic 
catheters, an energy delivery of 40 watts was usually necessary 
to overcome the system’s soft contact force.
The MNS provides precise and stable catheter positioning 
which gives it the potential to improve the efficacy of ablation 
procedures. We found, however, that catheter navigation in 
the small atrium was more difficult than in the large atrium 
due to limitations of the fixed curvature of the catheter’s distal 
tip. Our study has shown that MNS is more effective at ach-
ieving acute procedural success in persistent AF. Based on 
this observation, we speculate that the large atrium is more 
suitable for catheter navigation with the MNS. In a deviation 
from manual technique, during magnetic procedure the sh-
eath was usually positioned in the lower inferior vena cava fol-
lowing a more anterior septal puncture. This facilitated access 
to the anterior aspect of the right-sided pulmonary vein. 
Additionally, we took advantage of the magnetic vector-st-
oring capabilities of the MNS to reapply previously used vec-
tors. This allowed us to more easily obtain points in the elec-
tro-anatomic mapping portion of the procedure and to decrea-
se ablation time. 
Consistent with previous reports, no acute complications 
occurred in the MNS group. Our significant pericardial ef-
Table 5. Baseline patient characteristics in persistent atrial fibrilla-
tion
Conventional (n=27) MNS (n=17) p
Age (years) 58±11  59±6  0.60 
Male, n (%) 22 (81)  12 (70)  0.46
BMI (kg/cm
2) 26.0±2.4  26.0±2.1  0.93 
LAD (mm) 43.2±6.1  46.5±4.3  0.07 
EF (%) 58.4±8.0  56.8±8.2  0.59 
HTN (%) 17 (62)  5 (30)  0.07 
DM (%) 2 (7)  3 (18)  0.28
CAD (%) 1 (3)  2 (12)  0.11
MNS: magnetic navigation system, BMI: body mass index, LAD: left 
atrial diameter, HTN: hypertension, CAD: coronary artery disease
Table 6. Procedure parameters and acute/midterm procedural 






Total procedure time (minute) 294±77  358±54  0.01
Total fluoroscopic time (minute) 234±75 98±46 <0.0001
Acute procedural success, n (%) 24 (88)  15 (88)  0.92 
Significant PE, n (%) 03 (11)  0 (0)  NA
Stroke/TIA, n (%) 0 (0)  0 (0)   NA 
Total arrhythmia recurrence
  rate, n (%)
07 (26)  04 (24)  0.82 
AF recurrence, n (%) 03 (11)  03 (18)  0.59
AFL/AT recurrence, n (%) 04 (15)  1 (5)  0.36
MNS: magnetic navigation system, PE: pericardial effusion, AF: atri-
al fibrillation, AFL: atrial flutter, AT: atrial tachycardia, NA: not ap-
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fusion rate was high in the conventional group compared to 
previously reported data but the MNS was able to signifi-
cantly reduce this rate.
8) Inadvertent pericardial access during 
trans-septal puncture by an inexperienced trainee and car-
diac damage during ablation procedure with a stiff conven-
tional catheter may explain our results. No evidence of char 
formation or embolic complication was observed with the ir-
rigated tip catheters.
The main limitation of this study is its nonrandomized de-
sign. Nevertheless, our data is representative of the daily prac-
tice of an operator experienced in manual technique. Further-
more, we acknowledge that our results represent the initial ex-
perience of the operator and, consequently, all data should 
be cautiously interpreted as they may incorporate initial learn-
ing curve biases associated with the adoption of magnetic na-
vigation technology.
Conclusions
The MNS seems to be effective for catheter ablation of AF. 
The system’s benefits are particularly evident in the treatment 
of patients with persistent AF and a slightly dilated left atrium. 
Although several complications were encountered in the ma-
nual group, none were evident in MNS procedures. 
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